The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.15
Bid: 27.90
Ask: 28.10
Change: 0.45 (1.62%)
Spread: 0.20 (0.717%)
Open: 28.00
High: 28.50
Low: 27.65
Prev. Close: 27.70
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IQE plc: First commercially available 200mm VCSEL

11 May 2022 07:00

RNS Number : 0209L
IQE PLC
11 May 2022
 

IQE plc

Cardiff, UK

11 May 2022

 

Reach

 

 

IQE announces the world's first commercially available 200 mm (8") VCSEL wafer

 

· Enables the expansion of the 3D sensing market beyond the smartphone

· Based on IQE's patented 200mm technology for Wireless and Photonics compound semiconductor applications

IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, is pleased to announce the world's first commercially available 200 mm (8") VCSEL epiwafer.

IQE is leading the compound semiconductor industry in the development of 200mm epiwafers for wireless, sensing and display markets.

IQE's 200mm epiwafers will enable a step-change in unit economics for compound semiconductors, leading to the expansion of the market for IQE. The increase in wafer size will expand to new foundry partnerships, including Silicon-based foundries. Furthermore, it enables the integration of compound semiconductors on silicon, allowing adoption across a wider range of devices and applications.

IQE's 200mm VCSEL development is an example of the Company's continued innovation with the aim of expanding the market for wireless and 3D Sensing. 3D Sensing was made economical within premium smartphones in 2017 when IQE developed and scaled VCSEL epiwafers from 100mm to 150mm. The introduction of 200mm creates opportunities beyond the smartphone, into a broad range of intelligent connected devices and also enabling applications in the Metaverse.

Americo Lemos, Chief Executive Officer of IQE, commented:

"This is a critical milestone and establishes IQE as the global leader in scaling compound semiconductor technology to larger diameters. As we set out in our FY21 Results in March, a key focus area is growing our business by extending our roadmap to 200mm to establish new foundry partnerships. This advancement will expand the market for both Wireless and Photonics applications and service the growing demand for compound semiconductors as macro trends such as 5G and the Metaverse proliferate and capture more value for our technology."

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Tim Pullen

Amy Barlow

 

Headland Consultancy (Financial PR) + 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Antonia Pollock: +44 (0) 7789 954 356

 

embedded PR (Non-Financial PR)

Europe: Anja-Maria Hastenrath

Phone: +49 89 / 64913634-1

E-mail: ah@embedded-pr.de

 

United States: Cynthia Hoye

Phone: +1 408-858-2602

E-mail: ch@embedded-pr.com

 

ABOUT IQE

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across handset devices, telecoms infrastructure, connected devices and 3D sensing.

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging its intellectual property portfolio including know-how and patents, IQE produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with around 685 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.

 

http://iqep.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADGGDUSBBDGDG
Date   Source Headline
8th Mar 20133:00 pmRNSMerger Update
8th Jan 20138:39 amRNSStatement regarding press articles
31st Jul 20123:54 pmRNSDirectorate Change
10th Apr 20125:11 pmRNSDirector Dealings
27th Mar 20122:00 pmRNSPartnership Agreement
8th Feb 20124:10 pmRNSCompletion of Placing
17th Feb 20103:56 pmRNSNominated Adviser Change of Name
7th Aug 20094:42 pmRNSHolding(s) in Company
7th Aug 20094:30 pmRNSBondholders meeting
7th Aug 20093:51 pmRNSDirector Dealing in Shares
12th Jun 20081:42 pmRNSAdditional Listing
15th Apr 20087:01 amRNSAdditional Listing
7th Apr 200812:14 pmRNSDirector/PDMR Shareholding
28th Mar 200811:52 amRNSDirector/PDMR Shareholding
19th Mar 20087:00 amRNSDirector/PDMR Shareholding
17th Mar 20081:00 pmRNSContract Win
17th Mar 20087:01 amRNSFinal Results
28th Feb 20083:27 pmRNSHolding(s) in Company
19th Feb 20088:30 amRNSNotice of Results
25th Jan 20087:00 amRNSBank Facilities
17th Jan 20087:00 amRNSTrading Update
16th Jan 200811:15 amRNSBroker Appointment
15th Jan 200812:12 pmRNSDirector/PDMR Shareholding
9th Jan 20084:26 pmRNSAdditional Listing
7th Jan 20087:00 amRNSDirector/PDMR Shareholding
4th Jan 200812:46 pmRNSHolding(s) in Company
19th Dec 20077:30 amRNSAdditional Listing
18th Dec 20073:52 pmRNSSubstrate supply contract
13th Dec 20077:01 amRNSSuccessful Qualifications
9th Nov 200710:53 amRNSDirector/PDMR Shareholding
3rd Oct 200710:41 amRNSDirector/PDMR Shareholding
1st Oct 20072:44 pmRNSAdditional Listing
28th Sep 200710:14 amRNSContract Win
28th Sep 20078:12 amRNSInvestor Presentation
4th Sep 200712:03 pmRNSDirector/PDMR Shareholding
28th Aug 20072:17 pmRNSHolding(s) in Company
24th Aug 20073:36 pmRNSHolding(s) in Company
22nd Aug 20077:01 amRNSContract Win
22nd Aug 20077:01 amRNSInterim Results
15th Aug 20077:01 amRNSIFRS Transitional Stmnt - Amd
14th Aug 20077:01 amRNSIFRS Transitional Statement
13th Aug 20071:19 pmRNSRule 26 Compliance
2nd Aug 20078:39 amRNSResearch Consortium
1st Aug 20073:52 pmRNSNotice of Results
25th Jul 20071:35 pmRNSResult of AGM
11th Jul 20078:00 amRNSHolding(s) in Company
9th Jul 20077:00 amRNSTrading Statement
18th Jun 20073:35 pmRNSHolding(s) in Company
4th Jun 20074:15 pmRNSHolding(s) in Company
29th May 20074:48 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.